These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 17046788)

  • 1. Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity.
    Yan Y; Wang C
    J Mol Biol; 2006 Dec; 364(5):853-62. PubMed ID: 17046788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl dynamics of the amyloid-beta peptides Abeta40 and Abeta42.
    Yan Y; Liu J; McCallum SA; Yang D; Wang C
    Biochem Biophys Res Commun; 2007 Oct; 362(2):410-4. PubMed ID: 17709094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abeta40 protects non-toxic Abeta42 monomer from aggregation.
    Yan Y; Wang C
    J Mol Biol; 2007 Jun; 369(4):909-16. PubMed ID: 17481654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study.
    Lam AR; Teplow DB; Stanley HE; Urbanc B
    J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid beta-protein: monomer structure and early aggregation states of Abeta42 and its Pro19 alloform.
    Bernstein SL; Wyttenbach T; Baumketner A; Shea JE; Bitan G; Teplow DB; Bowers MT
    J Am Chem Soc; 2005 Feb; 127(7):2075-84. PubMed ID: 15713083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The turn formation at positions 22 and 23 in the 42-mer amyloid beta peptide: the emerging role in the pathogenesis of Alzheimer's disease.
    Murakami K; Masuda Y; Shirasawa T; Shimizu T; Irie K
    Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S169-79. PubMed ID: 20590832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation and stabilization model of the 42-mer Abeta radical: implications for the long-lasting oxidative stress in Alzheimer's disease.
    Murakami K; Irie K; Ohigashi H; Hara H; Nagao M; Shimizu T; Shirasawa T
    J Am Chem Soc; 2005 Nov; 127(43):15168-74. PubMed ID: 16248658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution NMR studies of Aβ monomer dynamics.
    Wang C
    Protein Pept Lett; 2011 Apr; 18(4):354-61. PubMed ID: 21222639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational, rotational and internal dynamics of amyloid beta-peptides (Abeta40 and Abeta42) from molecular dynamics simulations.
    Bora RP; Prabhakar R
    J Chem Phys; 2009 Oct; 131(15):155103. PubMed ID: 20568886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis.
    McLaurin J; Darabie AA; Morrison MR
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S130-5. PubMed ID: 14574627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer's disease.
    El-Agnaf OM; Mahil DS; Patel BP; Austen BM
    Biochem Biophys Res Commun; 2000 Jul; 273(3):1003-7. PubMed ID: 10891362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational dynamics of amyloid beta-protein assembly probed using intrinsic fluorescence.
    Maji SK; Amsden JJ; Rothschild KJ; Condron MM; Teplow DB
    Biochemistry; 2005 Oct; 44(40):13365-76. PubMed ID: 16201761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of new screening system for Alzheimer disease, in vitro Abeta sink assay, to identify the dissociation of soluble Abeta from fibrils.
    Sato N; Okochi M; Taniyama Y; Kurinami H; Shimamura M; Takeuchi D; Hamada H; Fukumori A; Kiyosue K; Taguchi T; Tanaka T; Miyasaka M; Takeda M; Ogihara T; Morishita R
    Neurobiol Dis; 2006 Jun; 22(3):487-95. PubMed ID: 16488151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distance measurement between Tyr10 and Met35 in amyloid beta by site-directed spin-labeling ESR spectroscopy: implications for the stronger neurotoxicity of Abeta42 than Abeta40.
    Murakami K; Hara H; Masuda Y; Ohigashi H; Irie K
    Chembiochem; 2007 Dec; 8(18):2308-14. PubMed ID: 18022992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M35 oxidation induces Abeta40-like structural and dynamical changes in Abeta42.
    Yan Y; McCallum SA; Wang C
    J Am Chem Soc; 2008 Apr; 130(16):5394-5. PubMed ID: 18376837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42.
    Liu R; Barkhordarian H; Emadi S; Park CB; Sierks MR
    Neurobiol Dis; 2005 Oct; 20(1):74-81. PubMed ID: 16137568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest.
    McLaurin J; Franklin T; Chakrabartty A; Fraser PE
    J Mol Biol; 1998 Apr; 278(1):183-94. PubMed ID: 9571042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template.
    Ha C; Park CB
    Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abeta(25-35) and its C- and/or N-blocked derivatives: copper driven structural features and neurotoxicity.
    Giuffrida ML; Grasso G; Ruvo M; Pedone C; Saporito A; Marasco D; Pignataro B; Cascio C; Copani A; Rizzarelli E
    J Neurosci Res; 2007 Feb; 85(3):623-33. PubMed ID: 17131391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional and fractal analyses of assemblies of amyloid beta protein subtypes [Abeta40 and Abeta42(43)] in canine senile plaques.
    Miyawaki K; Nakayama H; Matsuno S; Tamaoka A; Doi K
    Acta Neuropathol; 2002 Mar; 103(3):228-36. PubMed ID: 11907802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.